Evaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging

EJNMMI Research

Volumn 1, Issue 1, 2011, Pages 1-9

  Kant, Ritu ^a   Constantinescu, Cristian C ^a   Parekh, Puja ^a   Pandey, Suresh K ^a   Pan, Min Liang ^a   Easwaramoorthy, Balu ^a   Mukherjee, Jogeshwar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE NIFENE F 18; NICOTINIC RECEPTOR ALPHA4BETA2; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR OCCUPANCY; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; THALAMUS; TOBACCO DEPENDENCE;

EID: 84874418635     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-1-6     Document Type: Article

References (20)

1. Horti AG, Gao Y, Kuwabara H, Dannals RF: Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci 2010, 86:575-584.
2. Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J: Nicotinic α4β2 receptor imaging agents. Part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-(S)-3-pyrrolinyl) methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 2006, 33:294-304.
3. Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J: Effect of acetylcholinesterase inhibitors on the binding of nicotinic α4β2 receptor PET radiotracer, 18F-nifene: a measure of acetylcholine competition. Synapse 2007, 61:29-36.
4. Chefer SI, London ED, Koren AO, Pavlova OA, Kurian V, Kimes AS, Horti AG, Mukhin AG: Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse 2003, 48:25-34.
5. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG: Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 2006, 63:907-915.
6. Ding YS, Volkow ND, Logan J, Garza V, Pappas N, King P, Fowler JS: Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette. Synapse 2000, 35:234-237.
7. Valette H, Bottlaender M, Dolle F, Coulon C, Ottaviani M, Syrota A: Longlasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys. J Neurochem 2003, 84:105-111.
8. Schwartz RD, Kellar KJ: Nicotinic cholinergic receptor binding sites in brain: regulation in vivo. Science 1983, 220:214-216.
9. Marks MJ, Burch JB, Collins AC: Effects of chronic nicotine infusion on tolerance development and nicotine receptors. J Pharmacol Exp Ther 1983, 226:817-825.
10. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ: Increased nicotinic receptor in brains from smokers: membrane binding and autoradiographic studies. J Pharmacol Exp Ther 1999, 289:1545-1552.
11. Stolerman IP, Jarvis MJ: The scientific case that nicotine is addictive. Psychopharmacology 1995, 117:2-10.
12. Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin R, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH: Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. J Neurosci 2006, 26:8707-8714.
13. Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG, Vaupel DB, Pavlova O, Stein EA: Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J Nucl Med 2008, 49:1628-1635.
14. Sharma A, Brody AL: In vivo brain imaging of human exposure to nicotine and tobacco. Handb Exp Pharmacol 2009, 192:145-171.
15. McClernon FJ: Neuroimaging of nicotine dependence: key findings and application to the study of smoking-mental illness comorbidity. J Dual Diagn 2009, 5:168-178.
16. Constantinescu C, Mukherjee J: Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol 2009, 54:2885-2899.
17. Vaupel DB, Stein EA, Mukhin AG: Quantification of α4β2 nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380. Neuroimage 2007, 34:1352-1362.
18. Clarke PBS, Schwartz RD, Paul SM, Pert CB, Pert A: Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125-I]-α-bungarotoxin. J Neuroscience 1985, 5:1307-1315.
19. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ: A subtype of nicotinic cholinergic receptor in rat brain in composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. J Pharmacology Exp Ther 1992, 41:31-37.
20. Le Foll B, Chefer SI, Kimes AS, Shumway D, Goldberg SR, Stein EA, Mukhin AG: Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380. J Nucl Med 2007, 48:1492-1500.